TVARDI THERAPEUTICS, INC. Payments to Acquire Available-for-sale Securities
TVARDI THERAPEUTICS, INC. (TVRD) reported Payments to Acquire Available-for-sale Securities of $98.27 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2018-08-07
- TVARDI THERAPEUTICS, INC. payments to acquire available-for-sale securities for the quarter ending 2018-06-30 was $81.47M, a 11.01% decline year-over-year.
- TVARDI THERAPEUTICS, INC. payments to acquire available-for-sale securities for the quarter ending 2018-03-31 was $16.80M, a 159.44% increase year-over-year.
- TVARDI THERAPEUTICS, INC. payments to acquire available-for-sale securities for the quarter ending 2017-12-31 was $11.65M, a 1.08% increase year-over-year.
- TVARDI THERAPEUTICS, INC. payments to acquire available-for-sale securities for the quarter ending 2017-09-30 was $17.72M, a 22.69% increase year-over-year.
- TVARDI THERAPEUTICS, INC. payments to acquire available-for-sale securities for fiscal 2017 was $127.39M, a 85.58% increase from fiscal 2016.
- TVARDI THERAPEUTICS, INC. payments to acquire available-for-sale securities for fiscal 2016 was $68.65M, a 25.10% decline from fiscal 2015.
- TVARDI THERAPEUTICS, INC. payments to acquire available-for-sale securities for fiscal 2015 was $91.66M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-06-30 | $81.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $98.27M 10-Q · filed 2018-08-07 | $109.92M derived: sum of 3 quarters · filed 2018-08-07 | $127.64M derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | $16.80M 10-Q · filed 2018-05-09 | $28.45M derived: sum of 2 quarters · filed 2018-05-09 | $46.18M derived: sum of 3 quarters · filed 2018-05-09 | $137.72M derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-12-31 | $11.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $29.37M derived: sum of 2 quarters · filed 2018-03-15 | $120.92M derived: sum of 3 quarters · filed 2018-08-07 | $127.39M 10-K · filed 2018-03-15 |
| 2017-09-30 | $17.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $109.27M derived: sum of 2 quarters · filed 2018-08-07 | $115.75M 10-Q · filed 2017-11-02 | $127.27M derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-06-30 | $91.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $98.02M 10-Q · filed 2018-08-07 | $109.55M derived: sum of 3 quarters · filed 2018-08-07 | $123.99M derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | $6.48M 10-Q · filed 2018-05-09 | $18.00M derived: sum of 2 quarters · filed 2018-05-09 | $32.45M derived: sum of 3 quarters · filed 2018-05-09 | $52.50M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $11.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $25.97M derived: sum of 2 quarters · filed 2018-03-15 | $46.02M derived: sum of 3 quarters · filed 2018-03-15 | $68.65M 10-K · filed 2018-03-15 |
| 2016-09-30 | $14.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $34.50M derived: sum of 2 quarters · filed 2017-11-02 | $57.12M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $20.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $42.68M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $22.63M 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $91.66M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |